Skip to main content
Erschienen in:

23.08.2024 | Original Article

Fatigue and depression influence the prevalence of anxiety in patients with multiple sclerosis

verfasst von: Aliz Nyári, Zsófia Kokas, Szabolcs Szamosi, Zsanett Fricska-Nagy, Zsigmond Tamás Kincses, Judit Füvesi, Tamás Biernacki, Péter Klivényi, Krisztina Bencsik, Dániel Sandi

Erschienen in: Neurological Sciences | Ausgabe 1/2025

Einloggen, um Zugang zu erhalten

Abstract

Background

There is scarce information in Middle-Eastern Europe regarding the prevalence of anxiety in patients with multiple sclerosis (pwMS) and its association with different clinical-demographic factors.

Objective

We aimed to determine the prevalence of anxiety in Hungarian MS patients and to analyze associated factors.

Materials and methods

We evaluated 260 PwMS with the STAI-5 anxiety questionnaire. Fatigue (FIS), depression (BDI-II) and cognition (BICAMS) were also measured. Patients underwent standard neurological evaluations to evaluate Expanded Disability Status Scale (EDSS), and also measured the fine motor skills of the hand with the 9-hole peg test (9HPT), and the walking distance with the 25-foot walking test (T25FW).

Results

We identified 23.1% (N = 60) of the patients with anxiety (only state, trait or both forms concurrently). According to our two univariate, multivariable logistic regression analysis, fatigue and depression are strongly associated with both state and trait anxiety. In the absence of fatigue, the odds of trait anxiety are 82% lower (OR: 0.18; 95% CI: 0.06–0.53; p = 0.002), while in the case of pwMS without depression, the odds are reduced by 81% (OR: 0.19; CI95%= 0.07–0.51, p = 0.001). This association with fatigue (OR: 0.33; CI95%= 0.13–0.85, p = 0.021) and depression (OR: 0.14; CI95%=0.06–0.35; p < 0.001) can also be statistically verified on state anxiety. Importantly, a significant association with state anxiety was found in SPSM patients as well (OR: 34.94; CI95%=2.55-479.61; p = 0.008).

Conclusions

Anxiety was strongly associated with fatigue, depression, and secondary progressive disease form. These results emphasize the burden of psychiatric morbidity in pwMS.
Literatur
1.
Zurück zum Zitat Biernacki T, Sandi D, Fricska-Nagy Z et al (2020) Epidemiology of multiple sclerosis in Central Europe, update from Hungary. Brain Behav 10 (5), e01598 Biernacki T, Sandi D, Fricska-Nagy Z et al (2020) Epidemiology of multiple sclerosis in Central Europe, update from Hungary. Brain Behav 10 (5), e01598
2.
Zurück zum Zitat Walton C, King R, Rechtman L et al (2020) Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler 26(14):1816–1821PubMedPubMedCentralCrossRef Walton C, King R, Rechtman L et al (2020) Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler 26(14):1816–1821PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Vukusic S, Moreau T, Bouhour F, Adeleine P, Confavreux C (2001) [Multiple sclerosis: spontaneous course, natural history]. Rev Neurol (Paris) 157(Pt 1):8–9 Vukusic S, Moreau T, Bouhour F, Adeleine P, Confavreux C (2001) [Multiple sclerosis: spontaneous course, natural history]. Rev Neurol (Paris) 157(Pt 1):8–9
4.
Zurück zum Zitat Pham T, Jette N, Bulloch AGM et al (2018) The prevalence of anxiety and associated factors in persons with multiple sclerosis. Mult Scler Relat Disord 19:35–39PubMedCrossRef Pham T, Jette N, Bulloch AGM et al (2018) The prevalence of anxiety and associated factors in persons with multiple sclerosis. Mult Scler Relat Disord 19:35–39PubMedCrossRef
5.
Zurück zum Zitat Marrie RA, Reingold S, Cohen J et al (2015) The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler 21(3):305–317PubMedPubMedCentralCrossRef Marrie RA, Reingold S, Cohen J et al (2015) The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler 21(3):305–317PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Fiest KM, Walker JR, Bernstein CN et al (2016) Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis. Mult Scler Relat Disord 5:12–26PubMedCrossRef Fiest KM, Walker JR, Bernstein CN et al (2016) Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis. Mult Scler Relat Disord 5:12–26PubMedCrossRef
7.
Zurück zum Zitat Janssens AC, van Doorn PA, de Boer JB et al (2004) Perception of prognostic risk in patients with multiple sclerosis: the relationship with anxiety, depression, and disease-related distress. J Clin Epidemiol 57(2):180–186PubMedCrossRef Janssens AC, van Doorn PA, de Boer JB et al (2004) Perception of prognostic risk in patients with multiple sclerosis: the relationship with anxiety, depression, and disease-related distress. J Clin Epidemiol 57(2):180–186PubMedCrossRef
9.
Zurück zum Zitat Biernacki T, Sandi D, Kincses ZT et al (2019) Contributing factors to health-related quality of life in multiple sclerosis. Brain Behav 9 (12), e01466 Biernacki T, Sandi D, Kincses ZT et al (2019) Contributing factors to health-related quality of life in multiple sclerosis. Brain Behav 9 (12), e01466
10.
Zurück zum Zitat van Egmond E, van der Hiele K, van Gorp D et al (2022) Work difficulties in people with multiple sclerosis: the role of anxiety, depression and coping. Mult Scler J Exp Transl Clin 8(3):20552173221116282PubMedPubMedCentral van Egmond E, van der Hiele K, van Gorp D et al (2022) Work difficulties in people with multiple sclerosis: the role of anxiety, depression and coping. Mult Scler J Exp Transl Clin 8(3):20552173221116282PubMedPubMedCentral
11.
Zurück zum Zitat Wood B, van der Mei IA, Ponsonby AL et al (2013) Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis. Mult Scler 19(2):217–224PubMedCrossRef Wood B, van der Mei IA, Ponsonby AL et al (2013) Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis. Mult Scler 19(2):217–224PubMedCrossRef
12.
Zurück zum Zitat Steel Z, Marnane C, Iranpour C et al (2014) The global prevalence of common mental disorders: a systematic review and meta-analysis 1980–2013. Int J Epidemiol 43(2):476–493PubMedPubMedCentralCrossRef Steel Z, Marnane C, Iranpour C et al (2014) The global prevalence of common mental disorders: a systematic review and meta-analysis 1980–2013. Int J Epidemiol 43(2):476–493PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Zhang X, Song Y, Wei Z et al (2023) The prevalence and risk factors of anxiety in multiple sclerosis: a systematic review and meta-analysis. Front Neurosci 17:1120541PubMedPubMedCentralCrossRef Zhang X, Song Y, Wei Z et al (2023) The prevalence and risk factors of anxiety in multiple sclerosis: a systematic review and meta-analysis. Front Neurosci 17:1120541PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Giordano A, Granella F, Lugaresi A et al (2011) Anxiety and depression in multiple sclerosis patients around diagnosis. J Neurol Sci 307(1–2):86–91PubMedCrossRef Giordano A, Granella F, Lugaresi A et al (2011) Anxiety and depression in multiple sclerosis patients around diagnosis. J Neurol Sci 307(1–2):86–91PubMedCrossRef
15.
Zurück zum Zitat Marrie RA, Horwitz R, Cutter G et al (2009) The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated. Mult Scler 15(3):385–392PubMedCrossRef Marrie RA, Horwitz R, Cutter G et al (2009) The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated. Mult Scler 15(3):385–392PubMedCrossRef
16.
Zurück zum Zitat Theaudin M, Romero K, Feinstein A (2016) In multiple sclerosis anxiety, not depression, is related to gender. Mult Scler 22(2):239–244PubMedCrossRef Theaudin M, Romero K, Feinstein A (2016) In multiple sclerosis anxiety, not depression, is related to gender. Mult Scler 22(2):239–244PubMedCrossRef
17.
Zurück zum Zitat Ghahremani A, Mosa Farkhani S, Baniasadi M et al (2022) Personality traits of patients with multiple sclerosis and their correlation with anxiety and depression levels: a cross-sectional case-control study. Brain Behav 12 (5), e2596 Ghahremani A, Mosa Farkhani S, Baniasadi M et al (2022) Personality traits of patients with multiple sclerosis and their correlation with anxiety and depression levels: a cross-sectional case-control study. Brain Behav 12 (5), e2596
18.
Zurück zum Zitat Gammoh OS, Al-Smadi A, Alqudah A et al (2023) The association between fingolimod and mental health outcomes in a cohort of multiple sclerosis patients with stress. Eur Rev Med Pharmacol Sci 27(13):6018–6026PubMed Gammoh OS, Al-Smadi A, Alqudah A et al (2023) The association between fingolimod and mental health outcomes in a cohort of multiple sclerosis patients with stress. Eur Rev Med Pharmacol Sci 27(13):6018–6026PubMed
19.
Zurück zum Zitat Hillyer A, Sharma M, Kuurstra A et al (2023) Association between limbic system lesions and anxiety in persons with multiple sclerosis. Mult Scler Relat Disord 79:105021PubMedCrossRef Hillyer A, Sharma M, Kuurstra A et al (2023) Association between limbic system lesions and anxiety in persons with multiple sclerosis. Mult Scler Relat Disord 79:105021PubMedCrossRef
20.
Zurück zum Zitat Ellwardt E, Muthuraman M, Gonzalez-Escamilla G et al (2022) Network alterations underlying anxiety symptoms in early multiple sclerosis. J Neuroinflammation 19(1):119PubMedPubMedCentralCrossRef Ellwardt E, Muthuraman M, Gonzalez-Escamilla G et al (2022) Network alterations underlying anxiety symptoms in early multiple sclerosis. J Neuroinflammation 19(1):119PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat McDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121–127PubMedCrossRef McDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121–127PubMedCrossRef
22.
Zurück zum Zitat Polman CH, Reingold SC, Edan G et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria. Ann Neurol 58(6):840–846PubMedCrossRef Polman CH, Reingold SC, Edan G et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria. Ann Neurol 58(6):840–846PubMedCrossRef
23.
Zurück zum Zitat Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292–302PubMedPubMedCentralCrossRef Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292–302PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162–173PubMedCrossRef Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162–173PubMedCrossRef
25.
Zurück zum Zitat Bencsik K, Sandi D, Biernacki T et al (2017) [The multiple sclerosis Registry of Szeged]. Ideggyogy Sz 70(9–10):301–306PubMedCrossRef Bencsik K, Sandi D, Biernacki T et al (2017) [The multiple sclerosis Registry of Szeged]. Ideggyogy Sz 70(9–10):301–306PubMedCrossRef
26.
Zurück zum Zitat Lublin FD (2014) New multiple sclerosis phenotypic classification. Eur Neurol 72(Suppl 1):1–5PubMedCrossRef Lublin FD (2014) New multiple sclerosis phenotypic classification. Eur Neurol 72(Suppl 1):1–5PubMedCrossRef
27.
Zurück zum Zitat Lorscheider J, Buzzard K, Jokubaitis V et al (2016) Defining secondary progressive multiple sclerosis. Brain 139(Pt 9):2395–2405PubMedCrossRef Lorscheider J, Buzzard K, Jokubaitis V et al (2016) Defining secondary progressive multiple sclerosis. Brain 139(Pt 9):2395–2405PubMedCrossRef
28.
Zurück zum Zitat Zsido AN, Teleki SA, Csokasi K, Rozsa S, Bandi SA (2020) Development of the short version of the spielberger state-trait anxiety inventory. Psychiatry Res 291:113223PubMedCrossRef Zsido AN, Teleki SA, Csokasi K, Rozsa S, Bandi SA (2020) Development of the short version of the spielberger state-trait anxiety inventory. Psychiatry Res 291:113223PubMedCrossRef
29.
Zurück zum Zitat Sandi D, Rudisch T, Fuvesi J et al (2015) The Hungarian validation of the brief International Cognitive Assessment for multiple sclerosis (BICAMS) battery and the correlation of cognitive impairment with fatigue and quality of life. Mult Scler Relat Disord 4(6):499–504PubMedCrossRef Sandi D, Rudisch T, Fuvesi J et al (2015) The Hungarian validation of the brief International Cognitive Assessment for multiple sclerosis (BICAMS) battery and the correlation of cognitive impairment with fatigue and quality of life. Mult Scler Relat Disord 4(6):499–504PubMedCrossRef
30.
Zurück zum Zitat Beck A, Steer RA, Brown GK (1996) Manual for the Beck Depression Inventory-II. Psychological Corporation, San Antonio, TX Beck A, Steer RA, Brown GK (1996) Manual for the Beck Depression Inventory-II. Psychological Corporation, San Antonio, TX
31.
Zurück zum Zitat Losonczi E, Bencsik K, Rajda C et al (2011) Validation of the fatigue impact scale in Hungarian patients with multiple sclerosis. Qual Life Res 20(2):301–306PubMedCrossRef Losonczi E, Bencsik K, Rajda C et al (2011) Validation of the fatigue impact scale in Hungarian patients with multiple sclerosis. Qual Life Res 20(2):301–306PubMedCrossRef
32.
Zurück zum Zitat Fuvesi J, Bencsik K, Benedek K et al (2008) Cross-cultural adaptation and validation of the ‘Multiple sclerosis quality of Life Instrument’ in Hungarian. Mult Scler 14(3):391–398PubMedCrossRef Fuvesi J, Bencsik K, Benedek K et al (2008) Cross-cultural adaptation and validation of the ‘Multiple sclerosis quality of Life Instrument’ in Hungarian. Mult Scler 14(3):391–398PubMedCrossRef
33.
Zurück zum Zitat Erasmus LP, Sarno S, Albrecht H et al (2001) Measurement of ataxic symptoms with a graphic tablet: standard values in controls and validity in multiple sclerosis patients. J Neurosci Methods 108(1):25–37PubMedCrossRef Erasmus LP, Sarno S, Albrecht H et al (2001) Measurement of ataxic symptoms with a graphic tablet: standard values in controls and validity in multiple sclerosis patients. J Neurosci Methods 108(1):25–37PubMedCrossRef
34.
Zurück zum Zitat Tauil CB, Grippe TC, Dias RM et al (2018) Suicidal ideation, anxiety, and depression in patients with multiple sclerosis. Arq Neuropsiquiatr 76(5):296–301PubMedCrossRef Tauil CB, Grippe TC, Dias RM et al (2018) Suicidal ideation, anxiety, and depression in patients with multiple sclerosis. Arq Neuropsiquiatr 76(5):296–301PubMedCrossRef
35.
Zurück zum Zitat Butler E, Matcham F, Chalder T (2016) A systematic review of anxiety amongst people with multiple sclerosis. Mult Scler Relat Disord 10:145–168PubMedCrossRef Butler E, Matcham F, Chalder T (2016) A systematic review of anxiety amongst people with multiple sclerosis. Mult Scler Relat Disord 10:145–168PubMedCrossRef
36.
Zurück zum Zitat Boeschoten RE, Braamse AMJ, Beekman ATF et al (2017) Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. J Neurol Sci 372:331–341PubMedCrossRef Boeschoten RE, Braamse AMJ, Beekman ATF et al (2017) Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. J Neurol Sci 372:331–341PubMedCrossRef
38.
Zurück zum Zitat Korostil M, Feinstein A (2007) Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler 13(1):67–72PubMedCrossRef Korostil M, Feinstein A (2007) Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler 13(1):67–72PubMedCrossRef
39.
Zurück zum Zitat Moore H, Nair KPS, Baster K et al (2022) Fatigue in multiple sclerosis: a UK MS-register based study. Mult Scler Relat Disord 64:103954PubMedCrossRef Moore H, Nair KPS, Baster K et al (2022) Fatigue in multiple sclerosis: a UK MS-register based study. Mult Scler Relat Disord 64:103954PubMedCrossRef
40.
Zurück zum Zitat Broch L, Flemmen HO, Simonsen CS et al (2022) Fatigue in multiple sclerosis is associated with socioeconomic factors. Mult Scler Relat Disord 64:103955PubMedCrossRef Broch L, Flemmen HO, Simonsen CS et al (2022) Fatigue in multiple sclerosis is associated with socioeconomic factors. Mult Scler Relat Disord 64:103955PubMedCrossRef
41.
Zurück zum Zitat Wallis O, Bol Y, Kohler S, van Heugten C (2020) Anxiety in multiple sclerosis is related to depressive symptoms and cognitive complaints. Acta Neurol Scand 141(3):212–218PubMedCrossRef Wallis O, Bol Y, Kohler S, van Heugten C (2020) Anxiety in multiple sclerosis is related to depressive symptoms and cognitive complaints. Acta Neurol Scand 141(3):212–218PubMedCrossRef
42.
Zurück zum Zitat Mackay L, Johnson AM, Moodie ST, Rosehart H, Morrow SA (2021) Predictors of cognitive fatigue and fatigability in multiple sclerosis. Mult Scler Relat Disord 56:103316PubMedCrossRef Mackay L, Johnson AM, Moodie ST, Rosehart H, Morrow SA (2021) Predictors of cognitive fatigue and fatigability in multiple sclerosis. Mult Scler Relat Disord 56:103316PubMedCrossRef
43.
Zurück zum Zitat AlSaeed S, Aljouee T, Alkhawajah NM et al (2022) Fatigue, Depression, and anxiety among ambulating multiple sclerosis patients. Front Immunol 13:844461PubMedPubMedCentralCrossRef AlSaeed S, Aljouee T, Alkhawajah NM et al (2022) Fatigue, Depression, and anxiety among ambulating multiple sclerosis patients. Front Immunol 13:844461PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Margoni M, Preziosa P, Rocca MA, Filippi M (2023) Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis. Transl Psychiatry 13(1):264PubMedPubMedCentralCrossRef Margoni M, Preziosa P, Rocca MA, Filippi M (2023) Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis. Transl Psychiatry 13(1):264PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat van der Hiele K, Spliethoff-Kamminga NG, Ruimschotel RP, Middelkoop HA, Visser LH (2012) The relationship between self-reported executive performance and psychological characteristics in multiple sclerosis. Eur J Neurol 19(4):562–569PubMedCrossRef van der Hiele K, Spliethoff-Kamminga NG, Ruimschotel RP, Middelkoop HA, Visser LH (2012) The relationship between self-reported executive performance and psychological characteristics in multiple sclerosis. Eur J Neurol 19(4):562–569PubMedCrossRef
46.
Zurück zum Zitat Christodoulou C, Melville P, Scherl WF et al (2009) Negative affect predicts subsequent cognitive change in multiple sclerosis. J Int Neuropsychol Soc 15(1):53–61PubMedCrossRef Christodoulou C, Melville P, Scherl WF et al (2009) Negative affect predicts subsequent cognitive change in multiple sclerosis. J Int Neuropsychol Soc 15(1):53–61PubMedCrossRef
47.
Zurück zum Zitat Sandi D, Biernacki T, Szekeres D et al (2017) Prevalence of cognitive impairment among Hungarian patients with relapsing-remitting multiple sclerosis and clinically isolated syndrome. Mult Scler Relat Disord 17:57–62PubMedCrossRef Sandi D, Biernacki T, Szekeres D et al (2017) Prevalence of cognitive impairment among Hungarian patients with relapsing-remitting multiple sclerosis and clinically isolated syndrome. Mult Scler Relat Disord 17:57–62PubMedCrossRef
48.
Zurück zum Zitat Nyari A, Kokas Z, Szamosi S et al (2024) The 7-year follow-up of the Hungarian BICAMS validation cohort implies that cognitive performance may improve in multiple sclerosis patients. Neurol Sci Nyari A, Kokas Z, Szamosi S et al (2024) The 7-year follow-up of the Hungarian BICAMS validation cohort implies that cognitive performance may improve in multiple sclerosis patients. Neurol Sci
49.
Zurück zum Zitat Faravelli C, Alessandra Scarpato M, Castellini G, Lo Sauro C (2013) Gender differences in depression and anxiety: the role of age. Psychiatry Res 210(3):1301–1303PubMedCrossRef Faravelli C, Alessandra Scarpato M, Castellini G, Lo Sauro C (2013) Gender differences in depression and anxiety: the role of age. Psychiatry Res 210(3):1301–1303PubMedCrossRef
50.
Zurück zum Zitat Burns MN, Nawacki E, Siddique J, Pelletier D, Mohr DC (2013) Prospective examination of anxiety and depression before and during confirmed and pseudoexacerbations in patients with multiple sclerosis. Psychosom Med 75(1):76–82PubMedCrossRef Burns MN, Nawacki E, Siddique J, Pelletier D, Mohr DC (2013) Prospective examination of anxiety and depression before and during confirmed and pseudoexacerbations in patients with multiple sclerosis. Psychosom Med 75(1):76–82PubMedCrossRef
51.
Zurück zum Zitat Menculini G, Gentili L, Gaetani L et al (2023) Clinical correlates of state and trait anxiety in multiple sclerosis. Mult Scler Relat Disord 69:104431PubMedCrossRef Menculini G, Gentili L, Gaetani L et al (2023) Clinical correlates of state and trait anxiety in multiple sclerosis. Mult Scler Relat Disord 69:104431PubMedCrossRef
52.
Zurück zum Zitat Sparaco M, Miele G, Lavorgna L, Abbadessa G, Bonavita S (2022) Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic. Neurol Sci 43(5):2935–2942PubMedPubMedCentralCrossRef Sparaco M, Miele G, Lavorgna L, Abbadessa G, Bonavita S (2022) Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic. Neurol Sci 43(5):2935–2942PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat Jones KH, Ford DV, Jones PA et al (2012) A large-scale study of anxiety and depression in people with multiple sclerosis: a survey via the web portal of the UK MS Register. PLoS ONE 7 (7), e41910 Jones KH, Ford DV, Jones PA et al (2012) A large-scale study of anxiety and depression in people with multiple sclerosis: a survey via the web portal of the UK MS Register. PLoS ONE 7 (7), e41910
54.
Zurück zum Zitat McCabe MP (2005) Mood and self-esteem of persons with multiple sclerosis following an exacerbation. J Psychosom Res 59(3):161–166PubMedCrossRef McCabe MP (2005) Mood and self-esteem of persons with multiple sclerosis following an exacerbation. J Psychosom Res 59(3):161–166PubMedCrossRef
55.
Zurück zum Zitat Peres DS, Rodrigues P, Viero FT et al (2022) Prevalence of depression and anxiety in the different clinical forms of multiple sclerosis and associations with disability: a systematic review and meta-analysis. Brain Behav Immun Health 24:100484PubMedPubMedCentralCrossRef Peres DS, Rodrigues P, Viero FT et al (2022) Prevalence of depression and anxiety in the different clinical forms of multiple sclerosis and associations with disability: a systematic review and meta-analysis. Brain Behav Immun Health 24:100484PubMedPubMedCentralCrossRef
56.
Zurück zum Zitat Yousuf MS, Noh MC, Friedman TN et al (2019) Sensory Neurons of the Dorsal Root Ganglia Become Hyperexcitable in a T-Cell-Mediated MOG-EAE Model of Multiple Sclerosis. eNeuro 6 (2) Yousuf MS, Noh MC, Friedman TN et al (2019) Sensory Neurons of the Dorsal Root Ganglia Become Hyperexcitable in a T-Cell-Mediated MOG-EAE Model of Multiple Sclerosis. eNeuro 6 (2)
57.
Zurück zum Zitat Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on clinical trials of New agents in multiple sclerosis. Neurology 46(4):907–911PubMedCrossRef Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on clinical trials of New agents in multiple sclerosis. Neurology 46(4):907–911PubMedCrossRef
58.
Zurück zum Zitat Gil-Gonzalez I, Martin-Rodriguez A, Conrad R, Perez-San-Gregorio MA (2020) Quality of life in adults with multiple sclerosis: a systematic review. BMJ Open 10 (11), e041249 Gil-Gonzalez I, Martin-Rodriguez A, Conrad R, Perez-San-Gregorio MA (2020) Quality of life in adults with multiple sclerosis: a systematic review. BMJ Open 10 (11), e041249
Metadaten
Titel
Fatigue and depression influence the prevalence of anxiety in patients with multiple sclerosis
verfasst von
Aliz Nyári
Zsófia Kokas
Szabolcs Szamosi
Zsanett Fricska-Nagy
Zsigmond Tamás Kincses
Judit Füvesi
Tamás Biernacki
Péter Klivényi
Krisztina Bencsik
Dániel Sandi
Publikationsdatum
23.08.2024
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 1/2025
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-024-07737-9

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Neurologie

Einjährige Valaciclovir-Therapie schützt nicht vor Zoster-Rezidiv

Die Zoster Eye Disease Study (ZEDS) liefert gleich zwei ernüchternde Erkenntnisse: Eine einjährige Therapie mit niedrig dosiertem Valaciclovir kann weder einen Herpes zoster ophthalmicus (HZO) noch eine Post-Zoster-Neuralgie (PZN) verhindern.

Demenz-Leitlinie aktualisiert

  • 13.03.2025
  • Demenz
  • Nachrichten

Empfohlen wird jetzt auch eine Musiktherapie sowie bei unklarem diagnostischem Befund ein Tau-PET, und Depressive mit leichten kognitiven Störungen sollten eine Verhaltenstherapie erhalten – das sind einige wichtige Änderungen der aktuellen S3-Leitlinie Demenzen.

Frauen akkumulieren Tau-Protein schneller als Männer

Frauen mit einer hohen Beta-Amyloid-Last im Gehirn aggregieren mehr Tau-Protein als Männer mit vergleichbaren Amyloidwerten. Ähnliches gilt für Frauen mit einem ApoE4-Allel. Dafür sprechen die Daten einer Metaanalyse von Menschen im präklinischen Alzheimerstadium.

Frauen mit Apoplex in Deutschland nicht benachteiligt – oder doch?

Eine Analyse von Daten des statistischen Bundesamtes spricht dafür, dass Frauen in der Schlaganfallbehandlung nicht benachteiligt sind. Im Detail bleiben aber Fragen offen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.